Showing 41 - 60 results of 107 for search '"hydroxychloroquine"', query time: 0.05s Refine Results
  1. 41

    Hydroxychloroquine Therapy Led to the Diagnosis of Glucose-6-Phosphate Dehydrogenase (G6PD) Deficiency in an Elderly Patient with COVID-19 Involvement: A Case Report and Review of the Literature by Razieh Taghizadeh-Sarvestani, Hamid Reihani, Ali Ghanei-Shahmirzadi, Alireza Keshtkar, Parsa Yazdanpanahi

    Published 2022-01-01
    “…Here, we present the case of a 70-year-old man with no past medical history of G6PD deficiency that was admitted to our hospital due to COVID-19 infection and developed acute hemolytic anemia while receiving hydroxychloroquine (HCQ) medication for COVID-19-related pneumonia.…”
    Get full text
    Article
  2. 42
  3. 43

    Hydroxychloroquine plus personal protective equipment versus personal protective equipment alone for the prevention of laboratory-confirmed COVID-19 infections among healthcare workers: a multicentre, parallel-group randomised controlled trial from India by Rohina Joshi, Sudha Vidyasagar, Niveditha Devasenapathy, Rinaldo Bellomo, Vivekanand Jha, Chirag Patel, Vijay Kumar, Lachlan Donaldson, Oommen John, Balasubramanian Venkatesh, Michael John, Naomi Hammond, Jeyaraj Pandian, Ashwani Kumar, Arpita Ghosh, S Radhakrishnan, Rajib Paul, Bharath Kumar Tirupakuzhi Vijayaraghavan, Dorrilyn Rajbhandari, Sheila Nainan Myatra, Amritendu Bhattacharya, Sumaiya Arfin, Abhinav Bassi, Lachlan Hugh Donaldson, Naomi E Hammond, Mallikarjuna Kunigari, Cynthia Amrutha, Syed Haider Mehdi Husaini, Subir Ghosh, Santosh Kumar Nag, Hari Krishnan Selvaraj, Viny Kantroo, Kamal D Shah, Sheila Myatra, Amritendu Battacharya, Pavan Kumar Vecham, Evangeline Elvira, Gomathi Parthasarathy, Archana Ragunathan, Gnanavel Rajendra Kunjurao, Pavithra Sampath Kumar, Hilda Nirmala Kumari, Jayanthi Swaminathan, Murshid Cheriyeri Peediyekkal, Arun Chander Yadav, Aarthi Venkatramanan, Cynthia Amrutha Sukumar, Dharini Prasad, Krishnanda Nayak, Ravindra Prabhu, Rohini Bilagi, Akash Bhange, Bhumika Patel, Ekta Ramchandani, Jinesh Patel, Krupa Gandhi, N Prathyusha, Rayshma Rao Bonshlay Lakshmanan, S Hari Krishnan, Abhishek George Mehta, Mousumi Pradhan, Syed Haider Mehdi Husaini, Shahid Ali Siddique, Naved-ur Rahman, Mohammad Jamalludeen, Mounika Amarneni, Suresh Sankar, Vidya Rajesh Joshi, Alka Yadav, Nikhil Modi, Rinku Dahiya, Serena Knowles, Nikita Bathla, Fatima Butt

    Published 2022-06-01
    “…Participants randomised in HydrOxychloroquine Prophylaxis Evaluation were followed for 6 months.Setting 9 hospitals across India.Participants Healthcare workers in an environment with exposure to COVID-19 were randomised in a 1:1 ratio to hydroxychloroquine plus use of personal protective equipment or personal protective equipment alone. 886 participants were screened and 416 randomised (213 hydroxychloroquine arm and 203 personal protective equipment).Intervention Participants in intervention arm received 800 mg of hydroxychloroquine on day of randomisation and then 400 mg once a week for 12 weeks in addition to the use of personal protective equipment. …”
    Get full text
    Article
  4. 44

    Factors influencing therapeutic efficacy of denosumab against osteoporosis in systemic lupus erythematosus by Sung-Hwan Park, Seung-Ki Kwok, Wan-Uk Kim, Ji Hyeon Ju, Jiwon Yang, Youngjae Park, Jennifer Jooha Lee

    Published 2025-01-01
    “…The therapeutic efficacy of denosumab can be predicted by baseline BMD values, SLEDAI-2K scores and hydroxychloroquine use.…”
    Get full text
    Article
  5. 45

    Differential Cytotoxicity Responses by Dog and Rat Hepatocytes to Phospholipogenic Treatments by James K. Morelli, Paul J. Ciaccio

    Published 2013-01-01
    “…The lysosomal modulator Bafilomycin A1 (Baf) rescued dog cells from cytotoxicity caused by 3 phospholipogenic 5HT1b antagonists and hydroxychloroquine, but not fluoxetine, and rescued rat cells from hydroxychloroquine and NMTMB, a 5HT1b antagonist. …”
    Get full text
    Article
  6. 46
  7. 47

    Postchikungunya Chronic Inflammatory Rheumatism by Keith A. Sacco, Razvan M. Chirila

    Published 2016-01-01
    “…Symptoms were refractory to oral prednisone and hydroxychloroquine.…”
    Get full text
    Article
  8. 48

    Characteristics of COVID-19 clinical trials registered with ClinicalTrials.gov: cross-sectional analysis by Timothy F Platts-Mills, Christopher W Jones, Ashley L Woodford

    Published 2020-09-01
    “…The total planned enrolment for these hydroxychloroquine/chloroquine trials is over 200 000 participants, which represents 65% of the total planned enrolment for all registered trials of drugs or biologics. …”
    Get full text
    Article
  9. 49
  10. 50

    Accès psychotique aigu révélant un neurolupus : à propos d’un patient de 21 ans by JE Savadogo, I Compaoré, WJS Zabsonré/Tiendrébéogo, B Bagué, DD Ouédraogo

    Published 2025-01-01
    “…Il fut traité par de l’hydroxychloroquine et une corticothérapie à faible dose. …”
    Get full text
    Article
  11. 51

    Acute Generalized Exanthematous Pustulosis following SARS-CoV-2 Virus: Remdesivir as a Suspected Culprit by Fatemeh Mohaghegh, Parvaneh Hatami, Zeinab Aryanian, Farahnaz Fatemi, Zeinab Mohseni Afshar

    Published 2022-01-01
    “…We, hereby, present the first case of AGEP following treatment with remdesivir in a patient with COVID-19, without hydroxychloroquine use, which serves as a reminder to consider remdesivir as a possible causative agent when dealing with AGEP presentation in COVID patients.…”
    Get full text
    Article
  12. 52

    Omalizumab for Urticarial Vasculitis: Case Report and Review of the Literature by Misbah Nasheela Ghazanfar, Simon Francis Thomsen

    Published 2015-01-01
    “…Treatment options include oral antihistamines, oral corticosteroids, dapsone, colchicine or hydroxychloroquine. We describe a male patient with urticarial vasculitis who was treated with omalizumab (anti-IgE) with convincing results and provide a review of previous reports of patients with urticarial vasculitis treated with omalizumab.…”
    Get full text
    Article
  13. 53

    Systemic Lupus Erythematosus Presented with Bilateral Orbital Edema and Negative Serology by Manal Al-Khaldi, Manal Alsabbagh

    Published 2019-01-01
    “…The treatment usually comprises a combination of hydroxychloroquine and a tapering dose of systemic steroids. …”
    Get full text
    Article
  14. 54

    La controverse de Didier Raoult et de sa proposition thérapeutique contre la COVID-19 sur Twitter : analyse de réseaux et de discours by Nikos Smyrnaios, Panos Tsimboukis, Lucie Loubère

    Published 2021-09-01
    “…We propose to analyze both the network of actors and the network of the discourses mobilized in the controversy around Professor Didier Raoult and his Hydroxychloroquine-based therapeutic proposal against COVID-19. …”
    Get full text
    Article
  15. 55

    Chorea as the First and Only Manifestation of Systemic Lupus Erythematosus by Abdul Razzakh Poil, Fahmi Yousef Khan, Abdo Lutf, Mohammed Hammoudeh

    Published 2012-01-01
    “…The patient was started on aspirin and hydroxychloroquine and her chorea resolved after three weeks of followup. …”
    Get full text
    Article
  16. 56

    Q Fever Endocarditis in Northeast Iran by Ali Akbar Heydari, Ehsan Mostafavi, Masoumeh Heidari, Mina Latifian, Saber Esmaeili

    Published 2021-01-01
    “…According to the adjusted Duke criteria, Q fever endocarditis was confirmed, and the patient was successfully treated with doxycycline and hydroxychloroquine.…”
    Get full text
    Article
  17. 57

    Characteristics, pathogenic and therapeutic role of gut microbiota in immunoglobulin A nephropathy by Kaijin Yao, Lingqian Zheng, Wenmin Chen, Yina Xie, Chunling Liao, Tianbiao Zhou

    Published 2025-02-01
    “…Interestingly, therapies by modulating the gut microbiota, such as fecal microbiota transplantation, antibiotic treatment, probiotic treatment, Chinese herbal medicine Zhen Wu Tang treatment, gluten-free diet, and hydroxychloroquine treatment, can improve IgAN. In this review, the alteration of gut microbiota in IgAN, potential pathogenic roles of gut microbiota on IgAN and potential approaches to treat IgAN by modulating the gut microbiota are summarized.…”
    Get full text
    Article
  18. 58

    A Unique Case of Mycophenolate Induced Colitis after 10 Years of Use by Abhinav Goyal, Moiz Salahuddin, Yogesh Govil

    Published 2016-01-01
    “…A 31-year-old female with a history of lupus nephritis on Hydroxychloroquine, Prednisone, and Mycophenolate Mofetil (MMF) for 10 years presented to the hospital for ankle swelling. …”
    Get full text
    Article
  19. 59

    Panniculitis in Anti-MDA-5 Positive Juvenile Dermatomyositis: A Case Report by Semra Ayduran, Gulsah Kilbas, Saadet Nilay Tigrak, Selcuk Yuksel, Erdem Comut, Serkan Turkucar

    Published 2024-12-01
    “…His lesions were successfully controlled with hydroxychloroquine and azathioprine. This article presents a case regarding the rarity of panniculitis in juvenile dermatomyositis and its treatment strategy. …”
    Get full text
    Article
  20. 60

    Assessment of the impact of COVID-19 on the hearing organ by Jan Piotrowski, Bianka Nowińska, Izabela Hądzlik

    Published 2024-12-01
    “…Additionally, drugs included in COVID-19 treatment regimens and administrated in intensive care units (ICU), such as chloroquine, hydroxychloroquine, azithromycin and furosemide, may be the cause of hearing impairment, due to their potential ototoxic effect. …”
    Get full text
    Article